• Gossamer Bio Promotes Richard Aranda to CMO firstwordpharma
    June 22, 2021
    Gossamer Bio, Inc. (Nasdaq: GOSS) today announced that, Richard Aranda, M.D., previously Senior Vice President and Head of Clinical Development, will be promoted to Chief Medical Officer.
  • Gossamer Bio Appoints Sandra Milligan to its Board of Directors firstwordpharma
    June 15, 2021
  • Gossamer Bio secures $230m to support growth and expansion pharmaceutical-technology
    July 26, 2018
PharmaSources Customer Service